| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/02/2011 | EP1383761B1 Phenyl- and pyridyl-piperidines with tnf activity |
| 03/02/2011 | EP1363663B1 Nucleic acid mucosal immunization |
| 03/02/2011 | EP1064942B9 Sustained release preparation of a macrolide |
| 03/02/2011 | CN1674935B Biofunctional composition containing CpG or oligo-/polynucleotide and toxin or enterotoxin |
| 03/02/2011 | CN101982458A 3-amino-3-arylpropionic acid and preparation method thereof |
| 03/02/2011 | CN101084889B Ginkgolide freezing-dried powder injection and preparation method thereof |
| 03/01/2011 | US7897842 GnTIII expression in plants |
| 03/01/2011 | US7897757 for treating, preventing, inhibiting, or reducing obesity, insulin resistance, diabetes and any other disease, trait, or condition that is related to or will respond to the levels of PTP-1B in a cell or tissue |
| 03/01/2011 | US7897729 Polymeric immunoglobulin fusion proteins that target low affinity FcγReceptors |
| 03/01/2011 | US7897618 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 03/01/2011 | US7897590 Methods to mobilize progenitor/stem cells |
| 03/01/2011 | US7897384 Chondrocyte therapeutic delivery system |
| 03/01/2011 | US7897180 Enamel matrix protein composition for treatment of systemic inflammatory response |
| 03/01/2011 | US7897173 Tramadol hydrochloride with such as diclofenac sodium; reduced water solubility |
| 03/01/2011 | US7897161 External medicine for treating dermatitis |
| 03/01/2011 | US7897151 Anti-IgE vaccines |
| 03/01/2011 | CA2348954C A pharmaceutical composition for treating immune diseases |
| 03/01/2011 | CA2348488C Novel agents and methods for treatment and diagnosis of ocular disorders |
| 03/01/2011 | CA2301709C Epitope-bearing major histocompatibility complex class ii element/immunoglobulin chimeric molecules |
| 02/24/2011 | WO2011022606A2 Treatment of 'c terminus of hsp70-interacting protein' (chip) related diseases by inhibition of natural antisense transcript to chip |
| 02/24/2011 | WO2011022045A2 Apparatus and process for generating and harvesting adult stem cells and fluid associated with it from skin and omentum for medical, cosmetic, and veterinary use |
| 02/24/2011 | WO2011021678A1 Fused heterocyclic compound |
| 02/24/2011 | WO2011021203A2 Desferrioxamine-metal complexes for the treatment of immune-related disorders |
| 02/24/2011 | WO2011020748A1 A nutritional composition comprising bifidobacterium longum strains and reducing food allergy symptoms, especially in infants and children |
| 02/24/2011 | WO2010132764A3 Live-attenuated compositions for bacterial infections |
| 02/24/2011 | WO2009153434A8 Synthetic analogues of phosphatidyl-myo-inositol mannosides with an inhibitory activity on the inflammatory response |
| 02/24/2011 | US20110046606 Catheter injectable depot compositions and uses thereof |
| 02/24/2011 | US20110046546 Methods for treating headaches |
| 02/24/2011 | US20110046233 Gossypol derivatives, production method thereof and uses of same |
| 02/24/2011 | US20110046210 Substituted thiopenecarboxamides as ikk-beta serine-, threonine-protein kinase inhibitors |
| 02/24/2011 | US20110046202 Method for testing a subject thought to have or to be predisposed to asthma |
| 02/24/2011 | US20110046170 Novel pyrimidine-pyridine derivatives |
| 02/24/2011 | US20110046166 Purine derivatives as a3 adenosine receptor-selective agonists |
| 02/24/2011 | US20110046148 Spirocyclic Heterocycles Medicaments Containing Said Compounds, Use Thereof And Method For Their Production |
| 02/24/2011 | US20110046135 New compounds i |
| 02/24/2011 | US20110046131 Purines as pkc-theta inhibitors |
| 02/24/2011 | US20110046109 2,4,8-trisubstituted-8h-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy |
| 02/24/2011 | US20110046094 Methods and compositions for identifying and treating lupus |
| 02/24/2011 | US20110046085 Oral Immunostimulation of Fish from (1-4) Linked Beta-D-Mannuronic Acid |
| 02/24/2011 | US20110046077 Process for the extraction of mangiferin and isomangiferin |
| 02/24/2011 | US20110046075 Secreted Staphylococcus Aureus Proteins And Peptides For Use In Inhibiting Activation Of The Complement System |
| 02/24/2011 | US20110046073 Soluble lymphotoxin-beta receptor fusion protein and methods for inhibiting lymphotoxin beta-receptor signaling |
| 02/24/2011 | US20110045110 Nutritional Compositions Containing Punicalagins |
| 02/24/2011 | US20110045059 Vaccine against varicella zoster virus |
| 02/24/2011 | US20110045049 Immunomodulating compositions and methods of use |
| 02/24/2011 | US20110045046 Glycopeptides and methods of making and using them |
| 02/24/2011 | US20110045027 Adjuvant |
| 02/24/2011 | US20110045026 Production of fungal extracellular immune stimulating compounds |
| 02/24/2011 | US20110045023 Recombinant RSV Virus Expression Systems And Vaccines |
| 02/24/2011 | US20110045020 Nucleic acid comprising chimeric gene derived from hepatitis c virus |
| 02/24/2011 | US20110045016 Utilization of recombinant influenza viruses and modified vaccinia ankara virus (mva) with genes that encode for the toxoplasma gondii sag1 and sag2 surface proteins, as vaccines against toxoplasmosis |
| 02/24/2011 | US20110045015 Conjugated beta-1,3-linked glucans |
| 02/24/2011 | US20110045013 CAT Allergen Conjugates and Uses Thereof |
| 02/24/2011 | US20110045012 Anti-atheroma vaccine |
| 02/24/2011 | US20110045010 Anti-lps factor from parietaria judaica and methods of use thereof |
| 02/24/2011 | US20110045009 Cell Permeable Peptide |
| 02/24/2011 | US20110045002 Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
| 02/24/2011 | US20110044999 Il-32 modulators |
| 02/24/2011 | US20110044996 Neutralizing antibodies |
| 02/24/2011 | US20110044990 Antibody design using anti-lipid antibody crystal structures |
| 02/24/2011 | US20110044989 Zona Pellucida Binding Peptides, Expression Vectors, Compositions, and Methods for Species Specific Immunocontraception of Animals |
| 02/24/2011 | US20110044988 Methods of treatment using anti-mif antibodies |
| 02/24/2011 | US20110044982 Multifunctional linker protein containing an antibody against hemagglutinin, a conserved influenza antigen and an immunostimulating carrier binding domain |
| 02/24/2011 | US20110044980 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 02/24/2011 | US20110044974 Peptide analogues comprising at least one type of aminoacylaza-$g(b)<sp>3</sp>and the use thereof, in particular for therapy |
| 02/24/2011 | US20110044959 Novel composition of stem cells for transplantation tolerance |
| 02/24/2011 | US20110044946 Genetec regulation of host defense mechanisms by mucosal exposure to natural interferon alpha species |
| 02/24/2011 | US20110044941 Immunotherapy for reversing immune suppression |
| 02/24/2011 | US20110044912 Diagnostic And Therapeutic Epitope, And Transgenic Plant |
| 02/24/2011 | US20110044902 Modulation of the Immune Response |
| 02/24/2011 | US20110044901 Novel compounds |
| 02/24/2011 | US20110044898 Translocator protein ligands |
| 02/24/2011 | CA2771429A1 Use of mimotopes of alpha-synuclein epitopes for treating lewy body diseases |
| 02/24/2011 | CA2771277A1 Cloning and expression of arnox protein transmembrane 9 superfamily (tm9sf), methods and utility |
| 02/24/2011 | CA2771257A1 Desferrioxamine-metal complexes for the treatment of immune-related disorders |
| 02/24/2011 | CA2771228A1 Treatment of 'c terminus of hsp70-interacting protein' (chip) related diseases by inhibition of natural antisense transcript to chip |
| 02/24/2011 | CA2770062A1 A nutritional composition comprising bifidobacterium longum strains and reducing food allergy symptoms, especially in infants and children |
| 02/24/2011 | CA2769415A1 Modification of recombinant adenovirus with immunogenic plasmodium circumsporozoite protein epitopes |
| 02/23/2011 | EP2287309A1 Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease |
| 02/23/2011 | EP2287306A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 02/23/2011 | EP2287305A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 02/23/2011 | EP2287288A1 Animal protein free media for cultivation of cells |
| 02/23/2011 | EP2287285A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 02/23/2011 | EP2287156A1 2,4-Di(phenylamino)-pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 02/23/2011 | EP2286841A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 02/23/2011 | EP2286836A1 Immunostimulating agent |
| 02/23/2011 | EP2286834A2 Use of skin penetration enhancers and barrier disruption agents to enhance transcutaneous immune response |
| 02/23/2011 | EP2286832A1 Bacterial compositions for the treatment of cancer |
| 02/23/2011 | EP2286827A1 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 02/23/2011 | EP2286811A1 Chemokine receptor antagonists and methods of use thereof |
| 02/23/2011 | EP2286807A2 Medicament for preventive and/or therapeutic treatment of adhesion of bowel |
| 02/23/2011 | EP2285767A2 Stabilization of the composition of a mixture |
| 02/23/2011 | EP2285397A2 Immunotherapies employing self-assembling vaccines |
| 02/23/2011 | EP2285387A1 Nutrition for prevention of infections |
| 02/23/2011 | EP2285366A2 Molecules inhibiting a metabolic pathway involving the syk protein tyrosine kinase and method for identifying said molecules |
| 02/23/2011 | EP2285244A1 Sialic acid to support the immune system in the elderly |
| 02/23/2011 | EP1960427B1 Multimeric fc receptor polypeptides |
| 02/23/2011 | EP1928492B1 Immunological uses of immunodulatory compounds for vaccine and anti-infections disease therapy |
| 02/23/2011 | EP1919905B1 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-recptor tyrosine kinases |
| 02/23/2011 | EP1844028B1 MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF |